Episode

Lung Cancer – No Longer the Disease We Once Thought It Was

Podcast
DoctoRx Unscripted
Published
May 20, 2026
Duration seconds
2672
Processing state
not_requested
Canonical source
https://doctorx-unscripted.podbean.com/e/lung-cancer-%e2%80%93-no-longer-the-disease-we-once-thought-it-was/
Audio
https://mcdn.podbean.com/mf/web/zmgvmrm6qnhn6nny/AUDIO_PODCAST_DRXU_Nashville_Lung_Cancer_Episode_08_FULL_AUDIO_PODCAST_V03_051426_26wy7t.mp3
JSON
/v1/public/podcasts/doctorx-unscripted-7398035/episodes/lung-cancer-no-longer-the-disease-we-once-thought-it-was
Markdown
/podcast/doctorx-unscripted-7398035/lung-cancer-no-longer-the-disease-we-once-thought-it-was.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/doctorx-unscripted-7398035/episodes/lung-cancer-no-longer-the-disease-we-once-thought-it-was/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/doctorx-unscripted-7398035/lung-cancer-no-longer-the-disease-we-once-thought-it-was.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Join Dr. Tania Small, head of Medical Affairs at Bristol Myers Squibb, for a forward-looking episode of DoctoRx Unscripted, featuring leading thoracic oncologists Dr. Christine Lovly and Dr. Nate Pennell.Together, they examine innovations redefining what’s possible for patients with lung cancer: Biomarker-driven therapy and molecular profiling; Liquid biopsy and ctDNA testing; AI-assisted detection and radiomics; and Next-generation immunotherapies, including bispecifics, T-cell engagers, and personalized vaccines. They also share their perspectives on a critical challenge: translating scientific progress into real-world impact by expanding access and closing gaps in care.If you're working to advance oncology care—or interested in deepening your understanding of what’s shaping its future—this is a conversation you don’t want to miss.